Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunityBio, Inc. | Director | Common Stock | 3.12M | $10.5M | $3.36 | Jan 31, 2024 | Direct |
ImmunityBio, Inc. | Director | Restricted Stock Units | 45.7K | $185K | $4.04 | Feb 22, 2024 | Direct |
ImmunityBio, Inc. | Director | Stock Option (right to buy) | 159K | Feb 22, 2024 | Direct | ||
Viracta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 50K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIRX | Viracta Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
IBRX | ImmunityBio, Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Director |
IBRX | ImmunityBio, Inc. | Jan 31, 2024 | 3 | -$74.2K | 4 | Feb 2, 2024 | Director |
IBRX | ImmunityBio, Inc. | Sep 1, 2023 | 2 | $0 | 4 | Sep 6, 2023 | Director |
IBRX | ImmunityBio, Inc. | Aug 25, 2023 | 1 | $0 | 4 | Aug 28, 2023 | Director |
VIRX | Viracta Therapeutics, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
VIRX | Viracta Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
IBRX | ImmunityBio, Inc. | Mar 23, 2022 | 1 | $0 | 4 | Mar 25, 2022 | Director |
IBRX | ImmunityBio, Inc. | Dec 31, 2021 | 1 | $0 | 5 | Jan 28, 2022 | Director |
IBRX | ImmunityBio, Inc. | May 21, 2021 | 3 | -$2.02M | 4 | May 25, 2021 | Director |
IBRX | ImmunityBio, Inc. | May 5, 2021 | 2 | $99.9K | 4 | May 7, 2021 | Director |